IC

Ikarian Capital Portfolio holdings

AUM $494M
1-Year Est. Return 153.64%
This Quarter Est. Return
1 Year Est. Return
+153.64%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$672M
AUM Growth
+$124M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
266
New
Increased
Reduced
Closed

Top Buys

1
+$23.4M
2
+$15.9M
3
+$15.5M
4
XFOR icon
X4 Pharmaceuticals
XFOR
+$15.4M
5
RLMD icon
Relmada Therapeutics
RLMD
+$10.2M

Top Sells

1
+$29.5M
2
+$19.7M
3
+$18.8M
4
BMY icon
Bristol-Myers Squibb
BMY
+$17.9M
5
CLDX icon
Celldex Therapeutics
CLDX
+$15.8M

Sector Composition

1 Healthcare 98.54%
2 Consumer Staples 0.23%
3 Financials 0.12%
4 Industrials 0.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
201
– –
0
202
– –
0
203
– –
0
204
– –
0
205
– –
0
206
– –
-33,002
207
– –
0
208
– –
0
209
– –
0
210
– –
0
211
– –
0
212
– –
-54,694
213
– –
0
214
– –
0
215
– –
-62,796
216
– –
0
217
– –
-288,400
218
– –
0
219
– –
0
220
– –
0
221
– –
0
222
– –
-32,799
223
– –
0
224
– –
0
225
– –
0
7 8
9
10 11